Dehury; Sanjay Kumar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dehury; Sanjay Kumar.The latest application filed is for "novel processes for preparation of dapagliflozin or its solvates or co-crystals thereof".

Company Profile

9.12.13

Dehury; Sanjay Kumar - Hyderabad IN
Dehury; Sanjay Kumar - Assam IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof Grant 11,427,570 - Chava , et al. August 30, 2	2022-08-30
Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof Grant 11,299,477 - Chava , et al. April 12, 2	2022-04-12
Novel Processes For Preparation Of Dapagliflozin Or Its Solvates Or Co-crystals Thereof App 20210323939 - Vasireddi; Uma Maheswar Rao ; et al.	2021-10-21
Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof Grant 11,046,676 - Vasireddi , et al. June 29, 2	2021-06-29
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof Grant 10,800,809 - Dehury , et al. October 13, 2	2020-10-13
Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20200262820 - CHAVA; Satyanarayana ; et al.	2020-08-20
Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20200262821 - CHAVA; Satyanarayana ; et al.	2020-08-20
Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof Grant 10,730,859 - Chava , et al.	2020-08-04
Novel Process For Preparation Of Empagliflozin Or Its Co-crystals, Solvates And Their Polymorphs Thereof App 20200131163 - VASIREDDI; Uma Maheswar Rao ; et al.	2020-04-30
Processes For The Preparation Of Carfilzomib Or Pharmaceutically Acceptable Salts Thereof App 20190284231 - Dehury; Sanjay Kumar ; et al.	2019-09-19
Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof Grant 10,364,269 - Dehury , et al.	2019-07-30
An Improved Processes For The Preparation Of Carfilzomib Or Pharmaceutically Acceptable Salts Thereof App 20190085026 - Dehury; Sanjay Kumar ; et al.	2019-03-21
An Improved Process For The Preparation Of Pazopanib Or A Pharmaceutically Acceptable Salt Thereof App 20160280689 - CHAVA; Satyanarayana ; et al.	2016-09-29
Process for the preparation of sunitinib and its acid addition salts thereof Grant 9,206,163 - Dehury , et al. December 8, 2	2015-12-08
Process For The Perparation Of Sunitinib And Its Acid Addition Salts Thereof App 20150025252 - Dehury; Sanjay Kumar ; et al.	2015-01-22
Process for preparation of rufinamide Grant 8,871,945 - Davuluri , et al. October 28, 2	2014-10-28
Process For Preparation Of Rufinamide App 20130184469 - Davuluri; Ramamohan Rao ; et al.	2013-07-18
Process for making metal acetylacetonates Grant 7,282,573 - Chaudhuri , et al. October 16, 2	2007-10-16
Process for preparing quaternary ammonium tribromides Grant 7,005,548 - Choudhuri , et al. February 28, 2	2006-02-28
Process for preparing pyridinium fluorochromate (VI) Grant 6,852,859 - Choudhuri , et al. February 8, 2	2005-02-08
Process for preparing pyridinium fluorochromate (VI) App 20040133003 - Choudhuri, Mihir Kanti ; et al.	2004-07-08
Process for preparing quaternary ammonium tribromides App 20040126308 - Choudhuri, Mihir Kanti ; et al.	2004-07-01
Process for making metal acetylacetonates App 20040127690 - Chaudhari, Mihir Kanti ; et al.	2004-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.